Search results for "Goiter"

showing 10 items of 45 documents

Homozygous Resistance to Thyroid Hormone β: Can Combined Antithyroid Drug and Triiodothyroacetic Acid Treatment Prevent Cardiac Failure?

2017

Resistance to thyroid hormone β (RTHβ) due to homozygous THRB defects is exceptionally rare, with only five kindreds reported worldwide. Cardiac dysfunction, which can be life-threatening, is recognized in the disorder. Here we describe the clinical, metabolic, ophthalmic, and cardiac findings in a 9-year-old boy harboring a biallelic THRB mutation (R243Q), along with biochemical, physiologic, and cardiac responses to carbimazole and triiodothyroacetic acid (TRIAC) therapy. The patient exhibits recognized features (goiter, nonsuppressed thyroid-stimulating hormone levels, upper respiratory tract infections, hyperactivity, low body mass index) of heterozygous RTHβ, with additional characteri…

0301 basic medicineCardiac function curvemedicine.medical_specialtyendocrine systemGoiterendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismCase ReportsCardiovascularthyroidresistance to thyroid hormonehomozygous THRB mutation03 medical and health sciences0302 clinical medicineClinical ResearchInternal medicinemedicine2.1 Biological and endogenous factorsDecompensation2. Zero hungercardiac thyrotoxicosisbusiness.industryThyroidDilated cardiomyopathymedicine.disease3. Good health030104 developmental biologyEndocrinologymedicine.anatomical_structureCarbimazoleHeart Disease6.1 PharmaceuticalsBasal metabolic ratebusinessHormonemedicine.drug
researchProduct

Quantification of the risk of relapses after thyroid loboisthmusectomy for benign thyroid nodules

2006

AIM OF THE STUDY: To evaluate correlations between pre-operating epidemiological, clinical and diagnostic data and relapses concerning to patients operated on for benign thyroid nodules. MATERIAL AND METHODS: The AA. carried out a new ultrasonographic exam in 155 patients selected at random among 1012 treated by thyroid lobectomy between September 1976 and December 2002; 107 relapses were found (69%). The obtained data are analysed by chi2 test and a significant correlation between recurrence and data preceding first operation was found: non-homogeneous thyroid structure, multiple nodules, presence of peri-lesional halo, anti-thyroid antibodies, and non-adenomatous histological structure. C…

AdenomaAdultMaleChi-Square DistributionTime FactorsGoiterAge FactorsMiddle AgedGoitre relapse Thyroid lobectomyGraves DiseaseSex FactorsRecurrenceRisk FactorsThyroidectomyHumansFemaleThyroid NeoplasmsThyroid NoduleAgedFollow-Up StudiesGoiter NodularUltrasonography
researchProduct

Leukocyte migration test (LMT) in patients with thyroid disease: the response to human thyroid subcellular fractions.

1981

The response of circulating leukocytes to thyroid subcellular fractions was investigated in 19 patients with Graves' disease, 15 patients with Hashimoto's thyroiditis, 7 patients with toxic adenoma, 19 patients with nontoxic goiter and in 10 healthy students as control subjects. For this purpose, the leukocyte migration test of Soborg and Bendixen was performed against human crude thyroid extract (CTE), cell plasma membranes, nuclei, ribosomes, mitochondria and microsomes. Our results show positive LMT against: 1) CTE in patients with Graves' disease (61 +/- 13, p less than 0.001) and Hashimoto's thyroiditis (65 +/- 11, p less than 0.001) compared to controls (90 +/- 11); 2) cell plasma mem…

AdenomaAdultMaleendocrine systemmedicine.medical_specialtyLeukocyte migrationendocrine system diseasesAdolescentEndocrinology Diabetes and MetabolismCellThyroid GlandThyroiditisEndocrinologyInternal medicinemedicineLeukocytesHumansIn patientbusiness.industryGoiterThyroid diseaseThyroidThyroiditis AutoimmuneMiddle Agedmedicine.diseaseThyroid DiseasesGraves Diseasemedicine.drug_formulation_ingredientmedicine.anatomical_structureEndocrinologyCell Migration InhibitionMicrosomeFemalebusinessThyroid extractSubcellular FractionsJournal of endocrinological investigation
researchProduct

Congenital primary hypothyroidism with subsequent adenomatous goiter in a Turkish patient caused by a homozygous 10-bp deletion in the thyroid peroxi…

2006

Summary Objective  Congenital primary hypothyroidism occurs in 1 of 4000 births. Whereas the majority of the cases are due to developmental defects of the thyroid gland, 20% carry a defect in thyroid hormonogenesis. We report a Turkish boy who had goitrous hypothyroidism due to a mutation in the thyroid peroxidase (TPO) gene. Design  The TPO gene was sequenced directly from genomic DNA and cDNA which was transcribed from three RNA samples harvested from different parts of the patient's excised thyroid gland. Patient  The boy was thyroidectomized because of continuing growth of his thyroid gland and development of multiple nodes suspected of malignancy by ultrasound examination. Histopatholo…

AdenomaMaleThyroid Hormonesendocrine systemmedicine.medical_specialtyPathologyGoiterAdolescentTurkeyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentThyroid Function TestsBiologyIodide PeroxidaseThyroid function testsFrameshift mutationConsanguinityEndocrinologyThyroid peroxidaseInternal medicineCongenital HypothyroidismmedicineHumansIntracellular partmedicine.diagnostic_testHomozygoteThyroidThyroidectomyPrimary hypothyroidismmedicine.diseasePedigreeThyroxinemedicine.anatomical_structureEndocrinologyThyroidectomybiology.proteinGene DeletionGoiter NodularClinical Endocrinology
researchProduct

Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease

2018

CONTEXT: We hypothesized that TSH-receptor (TSHR) stimulating antibodies (TSAbs) are involved in oxidative stress mechanisms in patients with Graves disease (GD). METHODS: Nicotinamide adenine dinucleotide phosphate oxidase, isoform 2 (NOX2); oxidative parameters; and oxidative burst were measured in serum, urine, and whole blood from patients with GD and control subjects. Superoxide production was investigated in human embryonic kidney (HEK)-293 cells stably overexpressing the TSHR. Lipid peroxidation was determined by immunodot-blot analysis for protein-bound 4-hydroxy-2-nonenal (4-HNE) in human primary thyrocytes and HEK-293–TSHR cells. RESULTS: Serum NOX2 levels were markedly higher in …

AdultMale0301 basic medicineendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' diseaseClinical Biochemistry030209 endocrinology & metabolismContext (language use)medicine.disease_causeBiochemistryLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicinemedicineHumansEuthyroidClinical Research ArticlesTriiodothyroninebusiness.industryBiochemistry (medical)Toxic nodular goiterReceptors ThyrotropinMiddle AgedPrognosismedicine.diseaseGraves DiseaseRespiratory burstOxidative StressHEK293 Cells030104 developmental biologyEndocrinologychemistryFemaleLipid PeroxidationbusinessBiomarkershormones hormone substitutes and hormone antagonistsOxidative stressFollow-Up StudiesImmunoglobulins Thyroid-StimulatingThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Iatrogenic hypoparathyroidism after surgery for retrosternal goitre. A single centre retrospective analysis

2018

AIM: The aim of this study is to assess, retrospectively, the incidence of secondary hypoparathyroidism after total thyroidectomy in patients with retrosternal goitre. MATERIAL AND METHODS: From January 2009 to September 2015, 622 patients who undergone total thyroidectomy for goitre, were retrospectively observed. The patients were divided into two group: Group A, including 58 patients with retrosternal goitre and Group B, including 562 patients with in situ goitre. Those patients with diseases of the parathyroid glands, assumption of drugs modifying calcium metabolism and who received blood transfusions before or after surgery, were excluded from the study. In both groups, a total thyroid…

AdultMaleGoitreThyroid glandHypocalcemiaGoiterHypoparathyroidismRetrosternal goitreIncidenceIatrogenic DiseaseHypocalcaemiaSettore MED/21 - Chirurgia ToracicaLength of StayMiddle AgedSettore MED/18 - Chirurgia GeneraleThyroidectomyHumansCalciumFemaleGoitre; Hypocalcaemia; Hypoparathyroidism; Retrosternal goitre; Thyroid gland; ThyroidectomyAgedRetrospective Studies
researchProduct

Non-Immune Goiter and Hypothyroidism in a 19-Week Fetus: A Plea for Conservative Treatment

2009

Hypothyroidism was documented by cordocentesis at 19 weeks in a fetus with non-immune goiter. Intra-amniotic thyroxine was injected at 25 weeks when amniotic fluid volume increased. Psychomotor outcome was normal. We argue that intra-amniotic thyroxine should not be used to treat the hypothyroidism but only to correct the development of polyhydramnios.

AdultMalePolyhydramniosendocrine systemmedicine.medical_specialtyPediatricsPolyhydramniosGoiterAmniotic fluidendocrine system diseasesLevothyroxineThyrotropinUltrasonography PrenatalThyroid-stimulating hormonePregnancyCongenital HypothyroidismmedicineHumansFetusPregnancyGoiterbusiness.industryAmniotic Fluidmedicine.diseaseSurgeryCongenital hypothyroidismFetal DiseasesThyroxinePregnancy Trimester SecondPediatrics Perinatology and Child HealthFemaleCordocentesisbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugThe Journal of Pediatrics
researchProduct

Intrauterine therapy of goitrous hypothyroidism in a boy with a new compound heterozygous mutation (Y453D and C800R) in the thyroid peroxidase gene. …

2004

We report the results of intrauterine L-thyroxine therapy, and the long-term follow-up in a fetus who presented at 32 weeks' gestation with goitrous hypothyroidism, hyperextension of the neck, and polyhydramnios. Spontaneous delivery was possible and hypothyroidism improved. Molecular analysis revealed a new compound heterozygous mutation (Y453D/C800R) in the TPO gene.

AdultMalePolyhydramniosendocrine systemmedicine.medical_specialtyPolyhydramniosGoiterendocrine system diseasesCompound heterozygosityIodide PeroxidaseInjectionsLoss of heterozygosityHypothyroidismPregnancyInternal medicineCongenital HypothyroidismMedicineHumansThrombopoietinFetusFetal Therapiesbusiness.industryGoiterObstetrics and Gynecologymedicine.diseaseCongenital hypothyroidismFetal DiseasesThyroxineEndocrinologyRetreatmentGestationFemalebusinessFollow-Up StudiesAmerican journal of obstetrics and gynecology
researchProduct

Hashimoto Thyroiditis Coexistent with Papillary Thyroid Carcinoma

2005

Several studies report a higher rate of papillary thyroid carcinomas (PTC) in patients with Hashimoto thyroiditis (HT), indicating a possible correlation between the two diseases. We studied a group of 89 subjects undergoing surgery for thyroid carcinomas compared with a control group of 89 subjects operated on for normofunctioning goiter, and a second group of 47 patients undergoing total thyroidectomy for HT. Association with HT was found in 19 of the 71 PTC subjects (26.7%) and in 8 goiter patients (8.9%), which was a significant difference ( P < 0.02). Thirteen of the HT patients, mostly with the nodular form, showed coexistent PTC (27.6%). HT and PTC coexisted in several morphologi…

AdultMaleendocrine systemmedicine.medical_specialtyPathologyGoiterthyroid tumorendocrine system diseasesretrospective studymedicine.medical_treatmentHashimoto Diseasethyroidectomy MeSH: Adenocarcinoma PapillaryGastroenterologyThyroid carcinomaRetrospective StudieInternal medicinemedicineHumanshumanThyroid NeoplasmsThyroid cancerThyroid NeoplasmAgedRetrospective StudiesAutoimmune diseaseadenocarcinoma; adult; aged; article; female; Hashimoto disease; human; male; middle aged; retrospective study; thyroid tumor; thyroidectomy Adenocarcinoma Papillary; Adult; Aged; Female; Hashimoto Disease; Humans; Male; Middle Aged; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy [EMTREE medical terms]business.industryarticleThyroidectomyGeneral MedicineMiddle Agedmedicine.diseaseMajor duodenal papillaAdenocarcinoma PapillaryThyroidectomyImmunohistochemistryAdenocarcinomaFemalebusinessEMTREE medical terms: adenocarcinomaThe American Surgeon
researchProduct

Congenital goitrous primary hypothyroidism in two German families caused by novel thyroid peroxidase (TPO) gene mutations.

2013

Congenital hypothyroidism occurs with a prevalence of approximately 1:3 500. Defects in thyroid hormone synthesis which lead to goitrous hypothyroidism account for 10-15% of these cases. Several genetic defects have been characterized and mutations in the thyroid peroxidase (TPO) gene are the most common cause for dyshormonogenesis.So far, more than 80 mutations in the TPO gene have been described, resulting in a variable decrease in TPO bioactivity. Clinically TPO defects manifest with congenital primary goitrous hypothyroidism.We here present 2 children with congenital primary hypothyroidism, who were identified to have compound heterozygous TPO mutations. They both shared the same novel …

AdultMaleendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismMutation MissenseGene mutationmedicine.disease_causeCompound heterozygosityAutoantigensIodide Peroxidasefluids and secretionsEndocrinologyThyroid dyshormonogenesisThyroid peroxidaseInternal medicineGermanyIron-Binding ProteinsInternal MedicinemedicineCongenital HypothyroidismMissense mutationHumansFamilyMutationbiologybusiness.industryGoiterPrimary hypothyroidismInfant Newbornfood and beveragesGeneral MedicineExonsmedicine.diseaseCongenital hypothyroidismEndocrinologyembryonic structuresbiology.proteinFemalebusinessExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct